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Lipidomic analysisPrevious studies have demonstrated that gamma-linolenic acid (GLA) is effective against glioma cells under both
in vitro and in vivo conditions. In the present study we determined how GLA alone or in combination with
irradiation alters the fatty acid (FA) and lipid proﬁles, the lipid droplet (LD) content, the lipid biosynthetic
gene expression and the apoptosis of glioma cells. In GLA-treated cells direct correlations were found between
the levels of various FAs and the expression of the corresponding FA biosynthetic genes. The total levels of satu-
rated andmonosaturated FAs decreased in concert with the down-regulation of FASN and SCD1 gene expression.
Similarly, decreased FADS1 gene expression was paralleled by lowered arachidonic acid (20:4 n−6) and
eicosapentaenoic acid (20:5 n−3) contents, while the down-regulation of FADS2 expression was accompanied
by a diminished docosahexaenoic acid (22:6 n−3) content. Detailed mass spectrometric analyses revealed that
individual treatments gave rise to distinct lipidomic ﬁngerprints. Following uptake, GLA was subjected to
elongation, resulting in dihomo-gamma-linolenic acid (20:3 n−6, DGLA), which was used for the synthesis of
the LD constituent triacylglycerols and cholesteryl esters. Accordingly, an increased number of LDs were
observed in response to GLA administration after irradiation. GLA increased the radioresponsiveness of U87
MG cells, as demonstrated by an increase in the number of apoptotic cells determined by FACS analysis. In
conclusion, treatment with GLA increased the apoptosis of irradiated glioma cells, and GLA might therefore
increase the therapeutic efﬁcacy of irradiation in the treatment of gliomas.
© 2015 Elsevier B.V. All rights reserved.1. Introduction
Numerous studies have demonstrated that polyunsaturated fatty
acids (PUFAs) have anti-cancer activities and can be used as cancer
chemopreventive agents. The application of PUFAs has been conﬁrmed
to exert beneﬁcial effects against glioma under both in vitro and in vivo
conditions [1–9]. However, the exact mechanisms underlying the
anti-tumor effects of PUFAs are complex and remain poorly understood.
PUFAs induce oxidative stress through the generation of reactive
oxygen species (ROS) which results in enhanced lipid peroxidationenomics, Institute of Genetics,
of Sciences, Szeged H-6726,and decreased cell survival. This may be one of the main indirect causes
of the cytotoxicity of PUFAs [10]. Additionally, ROS can induce a dys-
function of themitochondria, which can lead to apoptosis [11]. Interest-
ingly, PUFA treatment can enhance the radiosensitivity of cancerous
cells, while it has proved to be radioprotective to normal cells [12,13].
This phenomenon has been attributed to the possible differences in
sensitivity of cancer and normal cells in combating lipid peroxidation
products [13].
It was shown earlier that cyclooxygenase inhibitors diminish the
gamma-linolenic acid (GLA)-induced radiosensitivity of astrocytoma
cells, and PUFAs may therefore induce radioresponsiveness through
prostanoid synthesis, though their cytotoxicity may not be related to
this effect [9]. There have been efforts to ﬁnd radiosensitizers to intensi-
fy radiotherapy for glioma, but none have resulted in improved survival
[14].
PUFA availability is known to alter the composition of the mem-
branes, their ﬂuidity and the way microdomains organize [15]. This
causes the release of heat shock signals, which lead to heat shock
protein (HSP) expression [15]. Membrane modulations, signal
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play essential roles in the etiology of several diseases, including
cancer [16].
Of the various PUFAs, the most extensive studies have been
performed with GLA in glioma treatment [1–3]. GLA enhances the
effects of radiotherapy on cancerous cells, at the same time exerting a
cytoprotective effect on normal cells [2,3]. In clinical experiments, the
infusion of GLA increased the length of survival [3]. Our previous studies
of themechanisms by which GLA and other PUFAs in combination with
irradiation exert their effects on glioma cells revealed the additive effect
of GLA treatment and irradiation on cell proliferation inhibition, as
conﬁrmed by the lactate dehydrogenase activity and gene expression
proﬁling [4].
The balance between fatty acid (FA) alimentation, synthesis, storage
and apoptosis inﬂuences cancer development. In comparison with
normal cells, de novo FA synthesis is activated during carcinogenesis
[17,18]. In consequence of their continuous proliferation, cancer cells
need increased FA biosynthesis to support lipoprotein synthesis
and cell membrane biogenesis [18,19]. Chajès et al. [17] found that
FA synthesis for cell proliferation is dispensable when FAs are
available in the medium. Furthermore, in normal cells, FA synthesis
is inhibited by exogenous FAs, while in cancerous cells the synthesis
is intensely active [19]. Although the correlation between the lipid
metabolism and cancer development has not yet been deciphered,
alterations in the lipid metabolism and the accumulation of lipids
in lipid droplets (LDs) have been implicated in carcinogenesis [13].
LD accumulation occurs in prenecrotic cancer tissues in vivo, and
LDs can therefore, serve as in vivo markers of cancer [20]. Moreover,
small-molecule drugs that target the LDs proved to induce endoplasmic
reticulum and oxidative stress and to exert cytotoxic effects in
diverse cancer cell lines [21], and to suppress hepatocellular carcinoma
in vivo [22].
The possible application of GLA as an adjuvant in clinical experi-
ments on the treatment of glioma necessitates a better understand-
ing of the overall effects of co-exposure to irradiation and GLA. In
this study we set out to investigate the dynamics of the FA and
lipid metabolism and storage and the rate of apoptosis by performing
experiments on the U87 MG glioblastoma cell line exposed to irradi-
ation and/or GLA. FA and lipid proﬁles were recorded by means of
mass spectrometric techniques and the expression of several genes
present in the biosynthetic pathway of FAs was evaluated, including
genes coding enzymes responsible for de novo synthesis of saturated
and monounsaturated FAs (FASN, SCD1 and SCD5) and desaturases
and elongases that participate in the synthesis of PUFAs (FADS1,
FADS2, ELOVL1, ELOVL2 and ELOVL5). We additionally measured the
expression of several heat shock genes, monitored the LD content
by ﬂuorescence microscopy, and determined the rate of apoptosis
by FACS analysis.Fig. 1.Rate of apoptosis of GLA-treated and/or irradiatedU87MG cells after a 48 h incubation.M
##p b 0.01 compared with GLA-treated cells.2. Results
2.1. Effects of GLA treatment and irradiation on the rate of apoptosis
To conﬁrm the apoptosis-inducing effects of GLA and irradiation,
FACS analysis was performed. As shown in Fig. 1, dose-dependent
increases in apoptotic cells occurred in response to 5 Gy or 10 Gy of
irradiation. Similarly, GLA alone signiﬁcantly increased the number of
apoptotic cells and, in parallel, decreased the total number of living
cells. When GLA was used in combination with irradiation, moderate
increases in apoptotic cell number were registered. As expected, the
most pronounced effects on cell survival and apoptosis were seen in
samples treated with 10 Gy irradiation and GLA.
2.2. Total FA analysis of GLA-treated cells by gas chromatography–mass
spectrometry
To determine how GLA treatment inﬂuences the total FA proﬁle of
U87 MG glioma cells, we used GC–MS (Fig. 2). GLA-treated cells
exhibited decreases in the total saturated and monounsaturated FAs
(SFAs and MUFAs, respectively; Fig. 2, inset). As expected, the level of
GLA increased on GLA treatment. The analysis also revealed a very signif-
icant, over 7-fold increase in the amount of the elongated derivative
dihomo-gamma-linolenic acid (20:3 n−6; DGLA). In parallel, the
contents of arachidonic acid (AA), eicosapentaenoic acid (EPA) and
docosahexaenoic acid (DHA) decreased.
2.3. Effects of irradiation, GLA and their combination on the lipid molecular
species proﬁle
To reveal the changes elicited by irradiation and/or GLA treatment in
the lipidomes of U87MG cells, high-sensitivity, high-resolution shotgun
proﬁlingwas carried out on an Orbitrap Elite hybrid tandemmass spec-
trometer. Altogether almost 250 lipid molecular species were identiﬁed
and quantiﬁed, each of which accounted for more than 0.4% within its
lipid class (Supplementary Table 1S). The data generated (i.e. 248 mo-
lecular species × 2 × 3 different treatments × 3 independent replicates)
served as a basis for partial least squares discriminant analysis (PLS-DA)
to test for possible lipid differences caused by the various treatment
conditions and also to assess overall experimental variation. PLS-DA is
a supervised multivariate classiﬁcation method that is useful for reduc-
ingmultidimensional data to lower dimensions, thereby simplifying the
visualization of complex datasets for exploratory analysis. It was con-
ﬁrmed by cross-validation and permutation test that the achieved
good separation (Fig. 3) is based on real signals. The PLS-DA analysis
indicated that the two highest ranking components, components 1
and 2, accounted for 58% and 9%, of the total variance, respectively. It
clearly emerged that component 1 captured most of the variationseans± S.E. values are shown (n=3), *p b 0.05 and **p b 0.01 comparedwith control cells,
Fig. 2. Total FA analysis of control and GLA-treated U87 MG cells by GC–MS. Data are
expressed as weight % (m/m) of total FA and expressed as means ± S.D. (n = 3),
*p b 0.025 (FDR b 0.05 calculated according to Benjamini and Hochberg [82]). DMA de-
notes dimethyl acetal from plasmalogen species. Inset: Sum of total saturated (SFA) and
monounsaturated FAs (MUFA).
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component 2 dose-dependently separated the gamma-ray treatments.
PLS-DA therefore demonstrated that the individual treatments gave
rise to distinct lipidomic ﬁngerprints.
The observed changes were further analyzed by comparing the
molecular species patterns of the individual treatments, which demon-
strated 183 statistically-signiﬁcant distinctions. The heatmap of selected
species (signiﬁcant in ANOVA, p b 0.007, FDR b 0.01, Fig. 4) convincingly
illustrates that the GLA supplementation dramatically rearranged the
lipidome of U87 cells.
In order to select appropriate alterations of explanatory relevance,
data were grouped according to changes in lipid class, fatty acyl chain
length and/or degree of unsaturation. As expected, GLA treatment
alone considerably increased the relative amounts of phospholipid spe-
cies containing 3 or 4 double bonds (Fig. 5). In agreement with the GC–
MSanalysis, electrospray ionization-MS/MS fragmentation experiments
revealed that, following the uptake, GLA is subjected to elongation, andFig. 3. Partial least squares discriminant analysis (PLS-DA) score plots of lipidomic
datasets. Values from 3 independent experiments are shown for control and treated cells.
Fig. 4. Heatmap representation of selected lipid molecular species of irradiated and/or
GLA-treated U87 MG cells. Selection was based on signiﬁcance in ANOVA, p b 0.007,
FDR b 0.01.the main FA incorporated was therefore DGLA (Figs. 2 and 5 inset).
Interestingly, no further desaturation (i.e. increase in AA)was observed.
A signiﬁcant fraction of GLA, after elongation to DGLA, was redirected to
lipid droplets and incorporated into triacylglycerol species (TAGs)
(Fig. 6A) and cholesteryl ester species (CholEs) (Fig. 6B).
Lipid class analysis of control and irradiated cells in combination
with or without GLA treatment did not reveal substantial changes in
the amounts of major membrane lipids (Fig. 7). Irrespectively of
Fig. 5. Changes in the relative amount of phospholipid species containing 3 or 4 double
bonds in response to GLA treatment of U87 MG glioma cells. Data are expressed as mol%
of total polar lipids and are presented as means± S.D. (n= 3), *p b 0.012 (FDR b 0.01 cal-
culated according to Storey and Tibshirani [81]). Inset: representative FA proﬁle resulting
from ESI-MS/MS fragmentation of phospholipids. PC, phosphatidylcholine; PI, phos-
phatidylinositol; PS, phosphatidylserine.
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irradiation was the dose-dependent increase in the content of
lysophosphatidylcholine (LPC) (Fig. 7). At a lipid species level, each
molecular species of LPC (Fig. 8) displayed a gradual accumulation in re-
sponse to gamma-ray treatment both in control and in GLA-treated
samples.
In order to identify lipidomic changes that may distinguish the
effects of irradiation + GLA treatment from those obtained with
irradiation alone, clustering, heatmap and ANOVA were run separately
on the corresponding datasets. The heatmap representations of selected
species, based on ANOVA results, revealed essentially different patterns
of lipid molecular species for the non-treated and GLA-supplemented
cells (Fig. 9). In the GLA-treated samples, the irradiation resulted in an
enhanced loss of several species of phosphatidylethanolamine (PE)
and phosphatidylserine (PS). Speciﬁc changes in the molecular species
of these phospholipid classes are visualized by grouping these speciesFig. 6. Incorporation of DGLA into LDs as a result of GLA treatment. A) Changes in triacylglycer
expressed as mol% of total polar lipids and are presented as means ± S.D. (n = 3), *p b 0.012according to the total number of their double bonds (Fig. 10). As
concerns the alterations in storage lipids, irradiation alone induced a
dose-dependent accumulation of TAG species and this elevation was
higher in species esteriﬁed with PUFAs (Fig. 11). GLA-co-treated cells
displayed elevated levels of TAG species containing PUFAs (double
bond number 4–12) in comparison with non-treated ones. In contrast
with non-supplemented cells, irradiation + GLA supplementation did
not induce further elevation of the TAG pools.
2.4. Evaluation of lipid droplet content of treated cells
We used a live cell LD-speciﬁc dye, AC-202, to evaluate the average
cellular LD content of GLA- and/or irradiation-treated U87 MG cells,
and control, untreated cells. Microscopic analysis revealed signiﬁcant
increases in LDamounts inGLA-treated and irradiated cells as compared
with irradiated control samples (Fig. 12A). Irradiation decreased the LD
content of the cells, while in GLA-treated cells, irradiation dose-
dependently increased the LD amount. Representative LD images of
irradiated cells with or without GLA treatment are presented in Fig. 12.
2.5. Gene expression analysis
In order to determine the effects of GLA and/or irradiation on FA
biosynthetic genes, the expression of FASN, ELOVL1, ELOVL2 and
ELOVL5 genes (Fig. 13), and SCD1, SCD5, FADS1, FADS2 and FADS3
genes (Fig. 14) was determined by using QRT-PCR.
While irradiation with 5 Gy demonstrated only a tendency to
enhance the FA synthase FASN expression, the higher dose (10 Gy)
up-regulated its expression signiﬁcantly (Fig. 13A). In contrast, GLA
treatment decreased the expression of FASN signiﬁcantly. Co-exposure
of U87 cells to 10 Gy + GLA caused a signiﬁcantly higher expression
level than that in GLA-treated cells (Fig. 13A). Irradiation + GLA treat-
ment did not signiﬁcantly alter the expression of FA elongases:
ELOVL1, ELOVL2 and ELOVL5 (Fig. 13B, C, D). Only ELOVL5was expressed
at a signiﬁcantly higher level in samples exposed to irradiation+GLAas
compared with samples treated with GLA alone (Fig. 13D).
Desaturases SCD1 and SCD5 were signiﬁcantly down-regulated
(p b 0.01) after GLA treatment (Fig. 14A, B), whereas their expressionol (TAG) molecular species and B) in cholesteryl ester (CholE) molecular species. Data are
(FDR b 0.01 calculated according to Storey and Tibshirani [81]).
Fig. 7. Lipid class analysis of control and irradiated cells in combination with or without GLA treatment. Data are expressed as mol% of total polar lipids and are presented as means± S.D.
(n=3), *p b 0.012 compared to control cells, #p b 0.012 compared to only GLA-treated cells, +p b 0.012 comparedwith only irradiated cells (FDR b 0.01 calculated according to Storey and
Tibshirani [81]). Cer, ceramide; CholE, cholesteryl ester; CL, cardiolipin;GlCer, glucosylceramide; LPC, lysophosphatidylcholine; LPE, lysophosphatidylethanolamine; PA, phosphatidic acid;
PC, phosphatidylcholine (diacyl), PC-O, phosphatidylcholine (alkyl–acyl); PE, phosphatidylethanolamine (diacyl); PE–Pl, phosphatidylethanolamine plasmalogen (alkenyl–acyl); PG,
phosphatidylglycerol; PI, phosphatidylinositol; PS, phosphatidylserine; SM, sphingomyelin; TAG, triacylglycerol.
1275O. Antal et al. / Biochimica et Biophysica Acta 1851 (2015) 1271–1282was not signiﬁcantly altered when irradiation was applied together
with GLA.
GLA treatment alone also diminished the expression of desaturases
FADS1 and FADS2 (p b 0.05) (Fig. 14C, D). Similarly as for SCD1 and
SCD5, the GLA-induced down-regulation was reversed to the control
levels in cells co-treated with GLA + irradiation (Fig. 14C, D). Similar
trends were observed in case of FADS3, although these changes were
not statistically signiﬁcant (Fig. 14E).
Since our results indicated that LD formation was modulated by the
applied treatments, we monitored the expression of PLIN3, the
perilipin-3 gene which has a special role in LD formation and stability.
The PLIN3 expression was increased signiﬁcantly in irradiated cells
(p b 0.01) (Fig. 15A), whereas GLA treatment was ineffective.
Co-treatment decreased the radiation-induced over-expression of
PLIN3 (Fig. 15A).
Several heat shock protein coding genes were also analyzed. GLA
treatment proved to induce HSP90AA1 expression by more than 3-fold
(Fig. 15B), but irradiation or irradiation + GLA had no effect on its
expression. While the expression of HSPB1 was moderately increased
after the treatments,HSPB2was unaffected (Fig. 15C, D). The statistical-
ly not signiﬁcant increase inHSPB2 expression in response to irradiation
was normalized by GLA, while the elevated HSPB1 level induced by
irradiation remained the same after GLA treatment.Fig. 8. Changes in lipid molecular species of lysophosphatidylcholine (LPC) in response to
irradiationwith orwithout GLA treatment. Data are expressed asmol% of total polar lipids
and presented asmeans± S.D. (n= 3), *p b 0.012 comparedwith control cells, #p b 0.012
compared with only GLA-treated cells, +p b 0.012 compared to only irradiated cells
(FDR b 0.01 calculated according to Storey and Tibshirani [81]).3. Discussion
The results of earlier cellular assays and in vivo experiments led to
the conclusion, that PUFAs could be useful adjuncts to irradiation in
cancer treatment [3,4,12,23]. We found that both GLA treatment and
irradiation induced apoptosis induction in U87 MG glioma cells, even
after incubation for 48 h. The moderate rate of apoptosis detected may
be due to the relatively short incubation time (48 h). However, our
results correlatewith thepreviousﬁnding that a longer period is needed
for apoptosis induction. In a human ADF astrocytoma cell line, for
example, fractionated irradiation (5 Gy on 4 successive days) caused
apoptosis, while exposure to 12.5 Gy caused necrosis [24].
In order to detect early changes in gene expression and in FA and
lipid proﬁles we analyzed all of our samples 48 h post-treatment.
Total FA analysis revealed that the levels of SFAs and MUFAs decreased
in concertwith the down-regulation of the FASN and SCD1 genes follow-
ing GLA treatment. FASN is a cytoplasmic multifunctional complex with
various enzymatic activities [25]. It is the only human enzyme which
can synthesize FAs de novo [26]. It is over-expressed or hyperactive in
numerous types of cancer, and its expression level correlates with
tumor development, aggressiveness and the rate of metastasis [32].
While FASN inhibition does not inﬂuence the growth and development
of normal cells, it arrests the cell cycle and induces programmed cell
death in cancer cells [29] and reduces tumor cell growth in vivo [27,
28]. FASN is considered to be an oncogene and, due to its suggested
role in cancer pathogenesis, it is also a potential therapeutic target [30,
31].We found that irradiation caused anup-regulation,while GLA treat-
ment resulted in a down-regulation of FASN (Fig. 13A). Although FASN
expression in tumors seemed to be unresponsive to nutritional signals
[27], in the present study irradiation-induced FASN over-expression
was attenuated by GLA treatment.
SCD1 is a Δ9 desaturase that catalyzes the synthesis of MUFAs from
SFAs [32]. SCD1 regulates the speed of lipogenesis and cell proliferation,
inﬂuences the membrane ﬂuidity by altering the SFA:MUFA ratio, and
affects membrane lipid domain compositions, thereby changing the
activities of plasma membrane proteins [33,34]. It has been suggested
that SCD1may have an anti-apoptotic effect, while its inhibition causes
apoptosis [19,35]. SCD5 enhances the production of CholE and PC, and
diminishes PE and TAG synthesis [33]. Sinner et al. [33] propose SCD5
as a therapeutic target in the treatment of brain tumors. In breast cancer
patients with a pathological complete response the SCD5 expression
was observed to be decreased signiﬁcantly [36]. In our study GLA
decreased the expressions of SCD1 and SCD5 more than 4-fold, while
irradiation was ineffective. Interestingly, irradiation attenuated the
effect of co-applied GLA (Fig. 14A, B).
Previous studies have investigated the lipid composition following
GLA supplementation. In rats, no changes were observed in the GLA or
DGLA content of tumors [37]. In vitro studies reported on changes in
Fig. 9. Heatmap representations revealing distinct patterns of selected lipid molecular species for the non-treated (left panel) and GLA-supplemented (right panel) cells. Selection was
based on the signiﬁcance in ANOVA, p b 0.007, FDR b 0.01.
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ment with GLA [38]. Following incorporation in C6 glioma cells, GLA
was elongated and desaturated and effectively replaced MUFAs, while
the SFA concentration remained constant [38]. In the present study
the GLA content of U87 MG cells was markedly increased after GLA
treatment (from 0% to ca. 2% of the total FAs). Most of the GLA was
then subjected to elongation to DGLA and incorporated effectively in
this form as a result of GLA treatment (the total FA% of DGLA increasedFig. 10. GLA treatment in combination with irradiation resulted in an enhanced loss of (A) pho
grouped according to the total number of double bonds (db), expressed as mol% of total pola
#p b 0.012 compared with only GLA-treated cells, +p b 0.012 compared with only irradiated cfrom 2% to 15%), though the corresponding elongase (ELOVL5) expres-
sion remained unchanged after incubation for 48 h. In contrast with
other studies on neuroblastoma [39], astrocytoma [9] and glioma [3,
38] models, where DGLA was found to be further desaturated to AA, in
our experiments the amount of AA was even lowered, this correlating
with the down-regulation of FADS1. Moreover, diminished levels of
EPA and DHA may be related to FADS1 and FADS2 down-regulation,
respectively. These ﬁndings are in accordance with the observationsphatidylethanolamine (PE), and (B) phosphatidylserine (PS) molecular species. Data are
r lipids and presented as means ± S.D. (n = 3), *p b 0.012 compared with control cells,
ells (FDR b 0.01 calculated according to Storey and Tibshirani [81]).
Fig. 11.Alterations in triacylglycerol (TAG) species inGLA- and/or irradiation-treated cells.
Data are expressed asmol% of total polar lipids and are presented asmeans± S.D. (n=3),
*p b 0.012 compared with control cells, #p b 0.012 compared with only GLA-treated
cells, +p b 0.012 compared with only irradiated cells (FDR b 0.01 calculated according to
Storey and Tibshirani [81]).
Fig. 12. Changes in relative LD content, assessed via determination of the average cellular area o
shown; n = 12 image ﬁelds with multiple cell clusters. Representative images of (A) irradiate
(B) 10 Gy-treated control and (C) GLA-co-treated U87 MG cells after 48 h. Dashed lines indica
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glycolytic and lipogenic enzyme-coding genes [40]. The suppressed
expression of lipogenic genes may be connected to a decrease in the
nuclear form of the transcription factor SREBP-1 (sterol-regulatory-ele-
ment-binding protein 1), the master regulator of lipogenic genes [41].
FADS1 (Δ5 desaturase) and FADS2 (Δ6 and Δ8 desaturase) are indis-
pensable for PUFA synthesis [32,42]. In agreement with previous
ﬁndings, both were down-regulated after GLA treatment in our experi-
ments (Fig. 14D, E). Several studies have reported that FADS2 was
down-regulated following PUFA treatment both in vitro and in vivo
[43–48]. In contrast with FADS1 and FADS2, the expression of FADS3,
which has been implicated in the maintenance of lipid homeostasis
[49,50], was not affected by GLA treatment.
Elongases are speciﬁc for substrates with a given chain length and
saturation [51]. ELOVL1, ELOVL2 and ELOVL5 have different substrate
speciﬁcities [25,52]. ELOVL2 elongates C20 and C22 PUFAs, ELOVL5
C18–C20 PUFAs, and ELOVL1 C18:0–C26:0 FAs [25,52–54]. The expres-
sion of the examined ELOVL1, ELOVL2 and ELOVL5was not altered signif-
icantly by any of the applied treatments (Fig. 13D).
PUFA treatment may inﬂuence the membrane ﬂuidity by altering
the saturated:unsaturated FA ratio and inmammalian cells a correlation
has been reported betweenmembrane perturbations andheat shock re-
sponse [55]. We therefore followed the changes in expression of several
hsp genes. The applied treatments did not alter the expression of HSPB2
signiﬁcantly, whereas irradiation (10 Gy), GLA treatment and their
combinations caused a signiﬁcant up-regulation of HSPB1. Similarly to
our results, Bucci et al. observed the dose-dependent up-regulation of
HSPB1 in the ADF human astrocytoma cell line; 5 Gy irradiation did not
affect its expression, whereas it was up-regulated in 12.5 Gy-irradiated
cells [24]. Hsp90 is a therapeutic target in glioblastoma multiforme: itsccupied by LDs, after a 48 h exposure to GLA and/or irradiation. (A)Means± S.E. values are
d (10 Gy) and (B) GLA-co-treated U87 MG cells after 48 h. stained ﬂuorescence images of
te cell cluster borders drawn with the aid of transmitted light images. Scale bar: 10 μm.
Fig. 13. Changes in the relative expression of FASN, ELOVL1, ELOVL2 and ELOVL5 following GLA treatment and/or irradiation.Means± S.E. values are shown, n= 3. *p b 0.05 and **p b 0.01
compared with control cells, #p b 0.05 and ##p b 0.01 compared with only GLA-treated cells.
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than a hundred targets which regulate the cell cycle, proliferation and
apoptosis [56]. We found that GLA treatment alone affected the expres-
sion of HSP90AA1 while irradiation + GLA normalized its expression
level to the baseline.
To recognize lipid changes as a consequence of irradiation and/or
GLA treatment, lipidomic datasets were analyzed by using the
data-mining PLS-DA method; this resulted in good separation of the
experiments into six distinguishable clusters, according to the six differ-
ent treatment combinations (Fig. 3). The ﬁrst component accounted for
almost 60% of the total variance. It clearly separated the samples treated
with and without GLA. Indeed, GLA treatment was able to reshape the
whole lipidome essentially, as a result of its incorporation (mainly in
the form of DGLA) into both the membrane and the storage lipids, i.e.
increasing the relative levels of PUFA-containing phospholipids and also
TAGs and CholEs, with parallel decreases in MUFA- and SFA-containing
species (Fig. 4 and Supplementary Table 1S).
It is well established that ionizing radiation strongly induces the
generation of ROS, and lipids are one of the major targets for these
radicals [57]. The PUFA-containing lipids are mostly affected by the
initial formation of phospholipid hydroperoxides and secondary lipid
peroxidation products, such as thiobarbituric acid-reactive substances
and 4-hydroxynonenal [58]. It has been proposed that phospholipase
A2 (PLA2) is activated by oxidized phospholipids, and protects mem-
branes from damage by peroxidation by preferentially cleaving the
oxidatively modiﬁed species [59,60]. Indeed, PLA2 is known to be acti-
vated by irradiation in order to repair the attacked phospholipids and
generate lipid mediators contributing to survival. PLA2 is therefore
able to diminish the efﬁcacy of radiotherapy in tumor models [61]. On
the other hand, PS is extremely sensitive to peroxidation, and the oxida-
tion of PS seems to be important for its externalization during apoptosis
and for the recognition of apoptotic cells by phagocytes [62]. We
demonstrated that the irradiation of GLA-treated glioma cells resulted
in an enhanced degradation of PUFA-containing species of PS and PE,
with the concomitant (GLA-independent) generation of LPC. TheseFig. 14. Alterations of SCD1, SCD5, FADS1, FADS2 and FADS3 expression following GLA treatm
***p b 0.001 compared with control cells, +p b 0.05 and ++p b 0.01 compared with only irra
GLA-treated cells.changes together suggest an increased level of lipid oxidation, conse-
quent PLA2 activation and the induction of the synthesis of HSPs [55,
63–65]. However, when it is taken into account that GLA treatment
promoted the radiation-induced apoptosis of U87 cells (measured by
Annexin V binding), it may be concluded that the PS externalization-
mediated apoptotic processes in GLA and irradiation co-treated samples
override the radioresistance and survival elicited by PLA2 activation and
HSP induction. When cells cannot ﬁnd sufﬁcient resources to restore
their functions, the stress may result in the initiation of apoptotic path-
ways and programmed cell death [55]. Interestingly, we did not detect
an increase in ceramide (Cer) generation (Supplementary Table 1S)
implying that the acid sphingomyelinase (ASMase)/Cer pathway is not
activated. It was also reported that, this pathway is not activated in
tissues exposed to fractionated (low-dose) radiotherapy [66,67]. Our
ﬁndings corroborate the hypothesis of the existence of an alternative
(low-dose) radiation-induced signaling pathway, involving plasma
membrane-initiated signals, such as scramblase activation and PS
externalization.
A signiﬁcant proportion of GLA/DGLA was redirected to LDs and
incorporated into TAGs (Fig. 6A) and CholEs (Fig. 6B). Very importantly,
the gamma-ray treatment of control glioma cells induced a dose-
dependent accumulation of TAGs, and especially species esteriﬁed
with PUFAs (Fig. 11). Interestingly, the GLA-treated cells per se exhibit-
ed elevated levels of TAG species containing PUFAs (db ≥ 4). The
enhanced PLA2 activation elicited by gamma-irradiation can produce
“intact” (not-oxidized) PUFAs, which may be stored in the LDs, thereby
serving as protective reservoirs during stress.
The biogenesis, morphology, development, trafﬁcking of LDs, lipid
storage and lipolysis are known to be determined by LD-associated pro-
teins [68,69]. Since we observed signiﬁcant dose-dependent increases
in TAG and CholE content in response to irradiation and GLA treatment,
we analyzed the possible changes in the expression of a lipid binding
protein, PLIN3. Perilipins are a multi-protein family that target LD
surfaces and regulate lipid storage and hydrolysis [70]. In good accord
with the increased TAG content of treated cells, we found that irradiationent and/or irradiation. Means ± S.E. values are shown, n = 3. *p b 0.05, **p b 0.01 and
diated cells (dose-matched), #p b 0.05, ##p b 0.01 and ###p b 0.001 compared with only
Fig. 15. Effects of GLA treatment and/or irradiation on expression of PLIN3, HSP90AA1, HSPB1 and HSPB2. Means± S.E. values are shown, n= 3. *p b 0.05, **p b 0.01 and ***p b 0.001 com-
pared with control cells, ++p b 0.01 compared with only irradiated cells, #p b 0.05 compared with only GLA-treated cells.
Fig. 16. SFA, MUFA and PUFA biosynthesis in humans. The scheme was prepared after
[32,52,73,74,75]. The meanings of the symbols: : GLA treatment diminished the expres-
sion of the respective gene; ↑: irradiation increased the expression of the respective gene.
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MG cells on incubation for 48 h (Fig. 15A). In contrast, it was previously
reported that the expression of PLIN3 protein decreases by 40–60% due
to the irradiation of U87 MG cells with 2 Gy [71]. Moreover, it seems
that different PUFAs have differential effects on the expression of PLIN3.
For example, PLIN3 was up-regulated by EPA treatment in goat mono-
cytes, but not affected by DHA [71]. In our study GLA treatment did not
alter the expression of PLIN3 in U87 MG cells, while when GLA was
added as an adjuvant to irradiation, the over-expression of PLIN3 was
normalized as compared with cells treated with irradiation alone. Confo-
calmicroscopy revealed a signiﬁcant increase in the amount of LD inGLA-
treated + irradiated cells as compared with irradiated control samples.
Further studies are needed to disclose the detailed mechanism and
kinetics of GLA- and irradiation-induced alterations in LD formation
and how these changes affect the sensitivity of cancer cells to apoptosis.
In summary, we detected speciﬁc changes in FA biosynthetic gene
expression in glioma cells after GLA and/or irradiation treatment. The
same samples yielded novel and detailed information on the FA and
lipid proﬁles revealing speciﬁc alterations which differentiated each
treatment protocol. The combination of two “omics” approaches
allowed a functional explanation of enhanced tumor cell death. It is sug-
gested that targeting the lipid composition by means of “membrane-
lipid therapy” [72], e.g. by PUFA supplementation, may alter the radio-
sensitivity of gliomas. The increased PUFA content is coupled with PS
oxidation and externalization and contributes to the induction of plas-
ma membrane-regulated apoptosis. A summary of the main pathways
of FA biosynthesis and how GLA treatment or irradiation inﬂuenced
the expression of the corresponding genes is presented in Fig. 16.
Further experiments are needed to compare our in vitro data on
gene expression and lipidome changeswith in vivo results, and possibly
clinical samples. This might promote the design of optimal irradiation
protocols and possibly combination therapies involving the use of
PUFAs.
4. Methods
4.1. Materials
Lipid standards were obtained from Avanti Polar Lipids (Alabaster,
AL, USA). The solvents used for extraction and for MS analyses were of
liquid chromatographic grade from Merck (Darmstadt, Germany) and
Optima LC–MS grade from Thermo Fisher Scientiﬁc (Waltham, MA,
USA). All other chemicals were purchased from Sigma and were of the
best available grade.
4.2. Cell culturing and treatment
U87 MG (ATCC HTB-14™) glioma cells were cultured at 37 °C in 5%
CO2 at atmospheric pressure, in DMEM supplemented with 10% FCS.
500,000 cells were plated for gene expression and LTQ Orbitrap analysisin 6-well plates (Corning Costar). 2000 cells/well were plated on 8-well
Lab-Tek II chambered coverglass (Thermo Fisher Scientiﬁc) for confocal
microscopic analysis. 40,000 cells/well were plated in 24-well TC ﬂasks
in 500 μLmedium for FACS analysis. Cellswere incubated for 24 h before
treatment. Cells were treated with GLA ester (Ubichem Research, Buda-
pest, Hungary) at 50 μM. In the event of co-treatment with irradiation
1 h after GLA treatment cells were exposed to 5 or 10 Gy irradiation
and then incubated for 48 h. Irradiation was performed as described
previously [4]. All measurements were carried out with three indepen-
dent biological replicates.
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Total RNAwas isolatedwith Accuzol™ Total RNAExtraction Solution
(Bioneer, Daejon, South Korea), according to the manufacturer's
instructions. The quality and quantity of RNA were determined with
NanoDrop1000 Version 3.8.1. (Thermo Fisher Scientiﬁc, Wilmington,
DE, USA). 1.5 μg RNA was transcribed with the High Capacity cDNA
Reverse Transcription Kit (Applied Biosystems®, Life Technologies,
Foster City, CA, USA). cDNAwas diluted 8-fold. QRT-PCRwas performed
on a RotorGene 3000 instrument (Corbett Life Science, QIAGEN).
Gene-speciﬁc primers and SybrGreen ampliﬁcation protocol were
used as described previouslywith slightmodiﬁcations [76]. Supplemen-
tary Table 2S shows the primer sequences used in the study. The
reaction mix was prepared with 4.5 μL cDNA, 0.5 μL primer (10 pM)
and 5 μL FastStart SYBR Green Master (Roche Diagnostics, USA). PCR
was performed with 55 cycles of the following protocol: 1. 95 °C for
10min; 2. 95 °C for 15 s; 3. 60 °C for 10 s; and 4. 72 °C for 20 s. Ct values
were determined and ampliﬁcation speciﬁcity was veriﬁed by melting
curve analysis. Data were normalized to the average of two control
genes (HPRT1 and PPIA). ΔΔCt values were calculated to compare the
expression of treated cells with that of control cells. Signiﬁcance was
determined by using Welch's t-test.
4.4. Evaluation of LD content with confocal microscopy
To determine LD content, live cells were stained for 30 min with
25 μMAC-202, a ﬂuorescent LD-speciﬁc dye [21,77]. Olympus Fluoview
FV1000 confocal laser scanning microscope (Olympus Life Science
Europa GmbH, Hamburg, Germany) with a UPLSAPO 20× (dry,
NA:0.75) objective was used to visualize U87 MG cells containing LDs.
Eight-well LabTek II coverslip-bottom chambers (Thermo Fisher Scientif-
ic,Wilmington, DE, USA)were used for cell culturing and for each sample
at least 12 microscope ﬁelds were analyzed in 4 different replicate wells.
After 8-bit conversion, ﬂuorescence images were thresholded by using
Image J software. A ﬁxed intensity range of 50–255 and “dark back-
ground” optionswere used during thresholding. The “setmeasurements”
option of Image Jwas limited to “areameasurement” and “limit to thresh-
old”. The percentage of the area occupied by LDs was calculated from the
total cellular area (manual tracing of cell borders on transmission images
usingOlympus Fluoview software) and thresholded LDareas byusing the
“measure” function of Image J.
4.5. FACS analysis
U87 MG cells (40,000) were plated in 24-well tissue culture plates
(Corning Life Sciences) and were treated with GLA and/or irradiation.
After 48 h the cells were collected, and resuspended in Annexin
V binding buffer (0.01 M HEPES, 0.14 M NaCl and 2.5 mM CaCl2).
Annexin V-Alexa 488 (Life Technologies, 2.5:100) and propidium iodide
(10 μg/ml) (Sigma-Aldrich, Hungary) were added to the cells, which
were then kept for 15min in the dark at room temperature. After wash-
ing, the cells were analyzed on a FACSCalibur cytoﬂuorimeter (Becton
Dickinson). The percentage of the FL1 (AnnexinV-Alexa 488) positive
and FL3 (propidium iodide) negative early apoptotic cells and FL1
(AnnexinV-Alexa 488) positive and FL3 (propidium iodide) positive
late apoptotic cells were determined. For statistical signiﬁcance two
two-tailed Student's t-test was used.
4.6. Lipid extraction
After treatment, the cells were centrifuged, and the lipids were
extracted according to a modiﬁed Folch procedure as described by
Balogh et al. [64]. The lipid extract was reconstituted in 200 μL
chloroform:methanol 1:1 (by vol.). Lipid species were annotated
according to the updated comprehensive classiﬁcation system for
lipids [78].4.7. Mass spectrometry
MS analyses were performed on a LTQ-Orbitrap Elite instrument
(Thermo Fisher Scientiﬁc, Bremen, Germany) equipped with a robotic
nanoﬂow ion source TriVersa NanoMate (Advion BioSciences, Ithaca,
NY), using chips with the diameter of 5.5-mm spraying nozzles. The
ion source was controlled by Chipsoft 8.3.1 software. The ionization
voltages were +1.3 kV and −1.9 kV in positive and negative mode,
respectively, and the back-pressure was set at 1 psi in both modes.
The temperature of the ion transfer capillary was 250 °C.
For quantiﬁcation, 5 μL of lipid extract was spiked before the MS
measurement with an internal standard mix containing 114 pmol PC
D31-16:0/18:1, 40 pmol PE D31-16:0/18:1, 17 pmol PI D31-16:0/18:1,
30 pmol PS D31-16:0/18:1, 4 pmol PG D31-16:0/18:1, 1 pmol PA D31-
16:0/18:1, 2 pmol CL 56:0, 3 pmol Cer d18:1/17:0, 5 pmol GluCer
d18:1/12:0, 8 pmol SM d18:1/17:0, and 2 pmol TAG 51:3. Each spiked
extract was diluted with 300 μL chloroform:methanol 1:3 (by vol.),
and then divided into two parts, and 5% dimethylformamide (as an
additive in the negative ion mode) or 7.5 mM ammonium chloride (as
an additive in the positive ion mode) was added to the halves. The
lipid classes: PC (diacyl), PC-O (alkyl–acyl), LPC, SM, TAG and CholE
were detected and quantiﬁed in the positive ion mode, and PE (diacyl),
PE–Pl (alkenyl–acyl), PI, PG, CL, PA, PS, Cer and GluCer in the negative
ion mode. Each of the quantiﬁed lipid species accounted for more than
0.5% within its lipid class.
Lipidswere identiﬁed by LipidXplorer software [79] bymatching the
m/z values of their monoisotopic peaks to the corresponding elemental
composition constraints. The mass tolerance was 2 ppm and the
intensity threshold was set according to the noise level reported by
Xcalibur software (Thermo Scientiﬁc). Statistical analyses of the
lipidomic datasets were performed with MetaboAnalyst [80], according
to Storey and Tibshirani [81] or to Benjamini and Hochberg [82], as
indicated.
Total FA analysis of the lipid extracts was carried out with a GC–MS
system (GCMS-QP2010, Shimadzu, Japan) equipped with a BPX-70
capillary column (10m×0.1mm ID, 0.2 μm ﬁlm thickness) as described
by Balogh et al. [72].
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.bbalip.2015.06.003.
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